Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
07/2003
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053931A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
07/03/2003WO2003053927A1 Piperazine derivative
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053918A2 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003WO2003053895A2 Copper deposition using copper formate complexes
07/03/2003WO2003053885A1 Method for forming a carbon-carbon or carbon-heteroatom linkage
07/03/2003WO2003053435A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003WO2003053409A1 Liposome composition for delivery of nucleic acid
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053359A2 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125494 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471038A1 Process for the preparation of perfluoroalkanesulfonic acid esters and salts thereof
07/03/2003CA2470964A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470808A1 Piperazine derivative
07/03/2003CA2470141A1 Method for forming a carbon-carbon or carbon-heteroatom linkage
07/03/2003CA2468831A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
07/03/2003CA2468627A1 Liposome composition for delivery of nucleic acid
07/02/2003EP1323709A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
07/02/2003EP1322654A1 Platinum complexes as antitumor agents
07/02/2003EP1322639A1 Substituted aryl ketones and their use as herbicides
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322168A1 Stabilised compositions having antibacterial activity
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
07/02/2003CN1427721A Peptide deformylase inhibitors
07/01/2003US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates
07/01/2003US6586474 Amidino compounds useful as nitric oxide synthase inhibitors
07/01/2003US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/01/2003US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea
07/01/2003US6586187 2-benzyloxycarbonylamino-3-(2-(4-(2-(3-benzylureido)-ethyl) -piperazin-1-yl)acetylamino)-propionic acid, for example; method of synthesis using Wang resins; various uses including anticancer, antiinflammatory and antiviral agents
06/2003
06/26/2003WO2003051894A1 Preparation of ionic liquids
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051825A1 Human adam-10 inhibitors
06/26/2003WO2003051795A2 Resin-bonded isonitriles
06/26/2003WO2003051360A1 Cis-imidazolines as mdm2 inhibitors
06/26/2003WO2003051359A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors
06/26/2003WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
06/26/2003US20030120115 Supported cobalt catalysts for nitrile hydrogenations
06/26/2003US20030120084 Forming 8-aminooctanoic acid hydrochloride by reacting halogenated carboxylic acid ester with metal cyanate and alcohol, then saponifying
06/26/2003US20030120070 Serotonin 5-HT1A and dopamin D2 receptor ligands
06/26/2003US20030120066 Synthetic peptides
06/26/2003US20030119982 Wet adhesion monomer and derived copolymers for latex paints
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119890 Relaxation of smooth muscle cells and reduce smooth muscle contractility; urinary incontinence; irritable bladder and bowel disease; asthma; hypertension; stroke
06/26/2003US20030119889 1,3-Disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119864 Farnesyl transferase inhibitors
06/26/2003US20030119850 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin) useful for treating psychological and nerveous system disorders
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119784 Treating and preventing diarrhea and scours
06/26/2003US20030119783 Aqueous compositions containing metronidazole
06/26/2003US20030119674 Substituted benzoylcyclohexane diones for use as herbicides
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2468783A1 Cis-imidazolines as mdm2 inhibitors
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321468A1 Hydantoin-based gold complex
06/25/2003EP1320534A1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1320364A1 The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
06/25/2003CN1426400A Process for producing 1,3-dialkyl-2-imidazolidinone compound
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1425653A 2,4,5-trisubstituted imidazole compounds and its preparing process and pharmaceutical use
06/24/2003US6583177 Leukotriene B4 antagonist compounds and method for treatment
06/24/2003US6583090 Hetaryl-substituted benzyl phenyl ethers, method for the production thereof, and their use for combating harmful fungi and animal pests
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
06/19/2003WO2003050062A2 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049541A2 Nematicidal trifluorobutenyl imidazole thioether derivatives
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114500 Nitrogen heterocycle inhibitors of aspartyl protease
06/19/2003US20030114495 Substituted imidazoles as cannabinoid receptor modulators
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114465 Substituted imidazole neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114425 Tiamenidine
06/19/2003US20030111353 Gold complex
06/19/2003CA2470111A1 Production of chirally pure .alpha.-amino acids and n-sulfonyl .alpha.-amino acids
06/19/2003CA2469241A1 Nematicidal trifluorobutenyl imidazole thioether derivatives